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Abstract
© Schattauer  2015.  Cardiac  ischaemia  and  reperfusion  leads  to  irreversible  injury  and
subsequent tissue remodelling. Initial reperfusion seems to shift arginine metabolism from nitric
oxide (NO) to polyamine formation.  This  may limit  functional  recovery at  reperfusion.  The
hypothesis  was  tested  whether  ischaemia/reperfusion  translates  such  a  shift  in  arginine
metabolism in a tumour necrosis factor (TNF)-α-dependent way and renin-angiotensin system
(RAS)-dependent  way into a sustained effect.  Both,  the early  post-ischaemic recovery and
molecular  adaptation to  ischaemia/reperfusion were analysed in  saline perfused rat  hearts
undergoing global no-flow ischaemia and reperfusion. Local TNF-α activation was blocked by
inhibition  of  TNF-α  sheddase  ADAM17.  To  interfere  with  RAS  captopril  was  administered.
Arginase  was  inhibited  by  administration  of  Nor-NOHA.  Long-term  effects  of
ischemia/reperfusion  on  arginine  metabolism  were  analysed  in  vivo  in  rats  receiving  an
established ischaemia/reperfusion protocol in the closed chest mode. mRNA expression analysis
indicated a  shift  in  the  arginine  metabolism from NO formation  to  polyamine metabolism
starting within 2 hours (h) of reperfusion and translated into protein expression within 24 h.
Inhibition  of  the  TNF-α  pathway  and  captopril  attenuated  these  delayed  effects  on  post-
ischaemic recovery. This shift in arginine metabolism was associated with functional impairment
of hearts within 24 h. Inhibition of arginase but not that of TNF-α and RAS pathways improved
functional  recovery  immediately.  However,  no  benefit  was  observed after  four  months.  In
conclusion, this study identified TNF-α and RAS to be responsible for depressed cardiac function
that occurred a few hours after reperfusion.
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